BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 36618379)

  • 21. The LUBAC participates in lysophosphatidic acid-induced NF-κB activation.
    Douanne T; Chapelier S; Rottapel R; Gavard J; Bidère N
    Cell Immunol; 2020 Jul; 353():104133. PubMed ID: 32450431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-type lectin receptor dectin-3 mediates trehalose 6,6'-dimycolate (TDM)-induced Mincle expression through CARD9/Bcl10/MALT1-dependent nuclear factor (NF)-κB activation.
    Zhao XQ; Zhu LL; Chang Q; Jiang C; You Y; Luo T; Jia XM; Lin X
    J Biol Chem; 2014 Oct; 289(43):30052-62. PubMed ID: 25202022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trimeric G protein-CARMA1 axis links smoothened, the hedgehog receptor transducer, to NF-κB activation in diffuse large B-cell lymphoma.
    Qu C; Liu Y; Kunkalla K; Singh RR; Blonska M; Lin X; Agarwal NK; Vega F
    Blood; 2013 Jun; 121(23):4718-28. PubMed ID: 23632891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies.
    Juilland M; Thome M
    Curr Opin Hematol; 2016 Jul; 23(4):402-9. PubMed ID: 27135977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple protein domains mediate interaction between Bcl10 and MALT1.
    Langel FD; Jain NA; Rossman JS; Kingeter LM; Kashyap AK; Schaefer BC
    J Biol Chem; 2008 Nov; 283(47):32419-31. PubMed ID: 18806265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells.
    Ferch U; Kloo B; Gewies A; Pfänder V; Düwel M; Peschel C; Krappmann D; Ruland J
    J Exp Med; 2009 Oct; 206(11):2313-20. PubMed ID: 19841089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The CARMA3-Bcl10-MALT1 Signalosome Drives NFκB Activation and Promotes Aggressiveness in Angiotensin II Receptor-Positive Breast Cancer.
    Ekambaram P; Lee JL; Hubel NE; Hu D; Yerneni S; Campbell PG; Pollock N; Klei LR; Concel VJ; Delekta PC; Chinnaiyan AM; Tomlins SA; Rhodes DR; Priedigkeit N; Lee AV; Oesterreich S; McAllister-Lucas LM; Lucas PC
    Cancer Res; 2018 Mar; 78(5):1225-1240. PubMed ID: 29259013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein kinase C-δ negatively regulates T cell receptor-induced NF-κB activation by inhibiting the assembly of CARMA1 signalosome.
    Liu Y; Song R; Gao Y; Li Y; Wang S; Liu HY; Wang Y; Hu YH; Shu HB
    J Biol Chem; 2012 Jun; 287(24):20081-7. PubMed ID: 22528498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural architecture of the CARMA1/Bcl10/MALT1 signalosome: nucleation-induced filamentous assembly.
    Qiao Q; Yang C; Zheng C; Fontán L; David L; Yu X; Bracken C; Rosen M; Melnick A; Egelman EH; Wu H
    Mol Cell; 2013 Sep; 51(6):766-79. PubMed ID: 24074955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CARMA3 Drives NF-κB Activation and Promotes Intervertebral Disc Degeneration: Involvement of CARMA3-BCL10-MALT1 Signalosome.
    Liu Y; Zhang G; Wu J; Meng Y; Hu J; Fu H; Yang D
    Inflammation; 2024 Apr; ():. PubMed ID: 38607566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CARD14-Mediated Activation of Paracaspase MALT1 in Keratinocytes: Implications for Psoriasis.
    Van Nuffel E; Schmitt A; Afonina IS; Schulze-Osthoff K; Beyaert R; Hailfinger S
    J Invest Dermatol; 2017 Mar; 137(3):569-575. PubMed ID: 27939769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Ca2+-dependent phosphatase calcineurin controls the formation of the Carma1-Bcl10-Malt1 complex during T cell receptor-induced NF-kappaB activation.
    Palkowitsch L; Marienfeld U; Brunner C; Eitelhuber A; Krappmann D; Marienfeld RB
    J Biol Chem; 2011 Mar; 286(9):7522-34. PubMed ID: 21199863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival.
    Bidère N; Ngo VN; Lee J; Collins C; Zheng L; Wan F; Davis RE; Lenz G; Anderson DE; Arnoult D; Vazquez A; Sakai K; Zhang J; Meng Z; Veenstra TD; Staudt LM; Lenardo MJ
    Nature; 2009 Mar; 458(7234):92-6. PubMed ID: 19118383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The CARMA3-BCL10-MALT1 (CBM) complex contributes to DNA damage-induced NF-κB activation and cell survival.
    Zhang S; Pan D; Jia XM; Lin X; Zhao X
    Protein Cell; 2017 Nov; 8(11):856-860. PubMed ID: 28717989
    [No Abstract]   [Full Text] [Related]  

  • 35. Card10 is a novel caspase recruitment domain/membrane-associated guanylate kinase family member that interacts with BCL10 and activates NF-kappa B.
    Wang L; Guo Y; Huang WJ; Ke X; Poyet JL; Manji GA; Merriam S; Glucksmann MA; DiStefano PS; Alnemri ES; Bertin J
    J Biol Chem; 2001 Jun; 276(24):21405-9. PubMed ID: 11259443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells.
    McAllister-Lucas LM; Ruland J; Siu K; Jin X; Gu S; Kim DS; Kuffa P; Kohrt D; Mak TW; Nuñez G; Lucas PC
    Proc Natl Acad Sci U S A; 2007 Jan; 104(1):139-44. PubMed ID: 17101977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CARMA3 is crucial for EGFR-Induced activation of NF-κB and tumor progression.
    Jiang T; Grabiner B; Zhu Y; Jiang C; Li H; You Y; Lang J; Hung MC; Lin X
    Cancer Res; 2011 Mar; 71(6):2183-92. PubMed ID: 21406399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The IRAK-1-BCL10-MALT1-TRAF6-TAK1 cascade mediates signaling to NF-kappaB from Toll-like receptor 4.
    Dong W; Liu Y; Peng J; Chen L; Zou T; Xiao H; Liu Z; Li W; Bu Y; Qi Y
    J Biol Chem; 2006 Sep; 281(36):26029-40. PubMed ID: 16831874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MALT1 Protease Activity Controls the Expression of Inflammatory Genes in Keratinocytes upon Zymosan Stimulation.
    Schmitt A; Grondona P; Maier T; Brändle M; Schönfeld C; Jäger G; Kosnopfel C; Eberle FC; Schittek B; Schulze-Osthoff K; Yazdi AS; Hailfinger S
    J Invest Dermatol; 2016 Apr; 136(4):788-797. PubMed ID: 26767426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The CBM Complex Underwrites NF-κB Activation to Promote HER2-Associated Tumor Malignancy.
    Pan D; Zhu Y; Zhou Z; Wang T; You H; Jiang C; Lin X
    Mol Cancer Res; 2016 Jan; 14(1):93-102. PubMed ID: 26392569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.